Head to Head Comparison: Anteris Technologies Global (NASDAQ:AVR) vs. Solana (NASDAQ:HSDT)

Anteris Technologies Global (NASDAQ:AVR) and Solana (NASDAQ:HSDT) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership.

Profitability

This table compares Anteris Technologies Global and Solana’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	N/A	N/A	N/A
Solana	-7,215.25%	-699.93%	-415.24%

Valuation and Earnings

This table compares Anteris Technologies Global and Solana”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$2.48 million	67.06	-$76.29 million	N/A	N/A
Solana	$520,000.00	30.53	-$11.74 million	($1,976.28)	-0.01

Solana has lower revenue, but higher earnings than Anteris Technologies Global.

Analyst Recommendations

This is a summary of current ratings for Anteris Technologies Global and Solana, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1	0	4	0	2.60
Solana	1	1	0	0	1.50

Anteris Technologies Global currently has a consensus target price of $16.50, suggesting a potential upside of 257.92%. Given Anteris Technologies Global’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Anteris Technologies Global is more favorable than Solana.

Institutional and Insider Ownership

18.6% of Solana shares are held by institutional investors. 4.0% of Anteris Technologies Global shares are held by company insiders. Comparatively, 17.9% of Solana shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Anteris Technologies Global beats Solana on 8 of the 11 factors compared between the two stocks.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

About Solana

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.